Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations

Annals of Nuclear Medicine

Volumn 24, Issue 5, 2010, Pages 395-401

  Kyoto, Yukishige ^a,b   Momose, Mitsuru ^b   Kondo, Chisato ^b   Itabashi, Michio ^b   Kameoka, Shingo ^b   Kusakabe, Kiyoko ^b  

^a Self Defense Forces Central Hospital   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Carcinoembryonic antigen (CEA); Positron emission tomography (PET); Recurrent colorectal cancer; Tumor volume

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; BLOOD; COLORECTAL TUMOR; LABORATORY DIAGNOSIS; MIDDLE AGED; PATHOLOGY; RECURRENT DISEASE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RECURRENCE; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 77954425207     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-010-0372-z     Document Type: Article

References (19)

1. EJ Martin M Cooperman L Carey J Minton 1980 Sixty-second-look procedures indicated primarily by rise in serial carcinoembryonic antigen J Surg Res 28 389 394 10.1016/0022-4804(80)90100-6 7392594
2. K Hine P Dykes 1984 Serum CEA testing in the post-operative surveillance of colorectal carcinoma Br J Cancer 49 689 693 1:STN:280:DyaL2c3jtF2jsA%3D%3D 6733018
3. J Minton J Hoehn D Gerber J Horsley D Connolly F Salwan, et al. 1985 Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study Cancer 55 1284 1290 10.1002/1097-0142(19850315)55:6<1284::AID- CNCR2820550622>3.0.CO;2-B 1:STN:280:DyaL2M7isValtA%3D%3D 3971297 (Pubitemid 15143405)
4. J McCall R Black C Rich J Harvey R Baker J Watts, et al. 1994 The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer Dis Colon Rectum 37 875 881 10.1007/BF02052591 1:STN:280:DyaK2czlslSgtA%3D%3D 8076486
5. C Moertel T Fleming J Macdonald D Haller J Laurie C Tangen 1993 An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer JAMA 270 943 947 10.1001/jama.270.8.943 1:STN:280:DyaK3szkslerug%3D%3D 8141873 (Pubitemid 23244732)
6. F Flanagan F Dehdashti O Ogunbiyi I Kodner B Siegel 1998 Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer Ann Surg 227 319 323 10.1097/00000658-199803000-00001 1:STN:280:DyaK1c7os1arsw%3D%3D 9527052 (Pubitemid 28131010)
7. P Flamen O Hoekstra F Homans E Van Cutsem A Maes S Stroobants, et al. 2001 Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET) Eur J Cancer 37 862 869 10.1016/S0959-8049(01)00049-1 1:CAS:528: DC%2BD3MXislGhtbw%3D 11313174 (Pubitemid 32323964)
8. R Huebner K Park J Shepherd J Schwimmer J Czernin M Phelps, et al. 2000 A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer J Nucl Med 41 1177 1189 1:STN:280:DC%2BD3czpslemtw%3D%3D 10914907
9. J Arnaud C Koehl M Adloff 1980 Carcinoembryonic antigen (CEA) in diagnosis and prognosis of colorectal carcinoma Dis Colon Rectum 23 141 144 10.1007/BF02587615 1:STN:280:DyaL3c3gtFSktA%3D%3D 7379666
10. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology. J Clin Oncol. 1996;14:2843-77.
11. M Choi K Lee J Chung D Lee J Jeong J Park, et al. 2005 Correlation between serum CEA level and metabolic volume as determined by FDG PET in postoperative patients with recurrent colorectal cancer Ann Nucl Med 19 123 129 10.1007/BF03027391 15909492
12. M Okubo Y Nishimura K Nakamatsu M Okumura T Shibata S Kanamori, et al. 2008 Static and moving phantom studies for radiation treatment planning in a positron emission tomography and computed tomography (PET/CT) system Ann Nucl Med 22 579 586 10.1007/s12149-008-0166-8 10.1007/s12149-008-0166-8 18756360
13. W Dupont WJ Plummer 1990 Power and sample size calculations. A review and computer program Control Clin Trials 11 116 128 10.1016/0197-2456(90)90005-M 1:STN:280:DyaK3c3mvFSjsw%3D%3D 2161310 (Pubitemid 20136185)
14. M Findlay H Young D Cunningham A Iveson B Cronin T Hickish, et al. 1996 Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil J Clin Oncol 14 700 708 1:CAS:528: DyaK28Xit1Gjsrk%3D 8622014
15. F Gutman J Alberini M Wartski D Vilain E Le Stanc F Sarandi, et al. 2005 Incidental colonic focal lesions detected by FDG PET/CT AJR Am J Roentgenol 185 495 500 10.2214/AJR.04.1654 16037527
16. J Konishi K Yamazaki E Tsukamoto N Tamaki Y Onodera T Otake, et al. 2003 Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings Respiration 70 500 506 10.1159/000074207 14665776 (Pubitemid 37526733)
17. Delbeke D, Martin W, Sandler M, Chapman W, Wright JJ, Pinson C. Evaluation of benign vs malignant hepatic lesions with positron emission tomography. Arch Surg. 1998;133:510-5 (discussion 5-6).
18. T Hany H Steinert G Goerres A Buck G von Schulthess 2002 PET diagnostic accuracy: improvement with in-line PET-CT system: initial results Radiology 225 575 581 10.1148/radiol.2252011568 12409597
19. G Locker S Hamilton J Harris J Jessup N Kemeny J Macdonald, et al. 2006 ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer J Clin Oncol 24 5313 5327 10.1200/JCO.2006.08.2644 1:CAS:528:DC%2BD28XhtlemurfN 17060676 (Pubitemid 46631379)